相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles
John K. Eaton et al.
NATURE CHEMICAL BIOLOGY (2020)
Metabolic Reprogramming in Triple-Negative Breast Cancer
Sun Xiangyu et al.
FRONTIERS IN ONCOLOGY (2020)
CELF6 modulates triple-negative breast cancer progression by regulating the stability of FBP1 mRNA
Xiaowei Yang et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Ferroptosis mediated DSS-induced ulcerative colitis associated with Nrf2/HO-1 signaling pathway
Yeru Chen et al.
IMMUNOLOGY LETTERS (2020)
GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis
Giovanni C. Forcina et al.
PROTEOMICS (2019)
miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
Peng Ge et al.
BMC CANCER (2019)
Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer
Hongzhou Cai et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
Ronan P. McLaughlin et al.
BREAST CANCER RESEARCH (2019)
GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues
Matilde Maiorino et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
Ricardo L. B. Costa et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis
Anja Jelinek et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway
Xia Li et al.
PHARMACOLOGICAL RESEARCH (2017)
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
Jong-Lyel Roh et al.
CANCER LETTERS (2016)
Metallothionein-1G Facilitates Sorafenib Resistance Through Inhibition of Ferroptosis
Xiaofang Sun et al.
HEPATOLOGY (2016)
分享论文
